Screener
Vir Biotechnology, Inc. VIR Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Vir Biotechnology, Inc.’s reported figures.
The source filing: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-031471
FAQ
- What is Vir Biotechnology, Inc.'s free cash flow?
- Vir Biotechnology, Inc. (VIR) reported free cash flow of -$132.78M in Q1 2026.
- How has Vir Biotechnology, Inc.'s free cash flow changed year-over-year?
- Vir Biotechnology, Inc.'s free cash flow decreased by 66.5% year-over-year, from -$79.75M to -$132.78M.
- What is the long-term trend for Vir Biotechnology, Inc.'s free cash flow?
- Over 4 years (2021 to 2025), Vir Biotechnology, Inc.'s free cash flow has grown at a 54.6% compound annual growth rate (CAGR), from -$69.41M to -$396.61M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Vir Biotechnology, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude